These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
276 related items for PubMed ID: 26621566
1. Relationship Among Strongyloides stercoralis Infection, Human T-Cell Lymphotropic Virus Type 1 Infection, and Cancer: A 24-Year Cohort Inpatient Study in Okinawa, Japan. Tanaka T, Hirata T, Parrott G, Higashiarakawa M, Kinjo T, Kinjo T, Hokama A, Fujita J. Am J Trop Med Hyg; 2016 Feb; 94(2):365-370. PubMed ID: 26621566 [Abstract] [Full Text] [Related]
2. Impairment of host immune response against strongyloides stercoralis by human T cell lymphotropic virus type 1 infection. Hirata T, Uchima N, Kishimoto K, Zaha O, Kinjo N, Hokama A, Sakugawa H, Kinjo F, Fujita J. Am J Trop Med Hyg; 2006 Feb; 74(2):246-9. PubMed ID: 16474078 [Abstract] [Full Text] [Related]
6. Treatment of strongyloidiasis in HTLV-1 and Strongyloides stercoralis coinfected patients is associated with increased TNFα and decreased soluble IL2 receptor levels. Salles F, Bacellar A, Amorim M, Orge G, Sundberg M, Lima M, Santos S, Porto A, Carvalho E. Trans R Soc Trop Med Hyg; 2013 Aug; 107(8):526-9. PubMed ID: 23843560 [Abstract] [Full Text] [Related]
9. Immunoepidemiologic studies of Strongyloides stercoralis and human T lymphotropic virus type I infections in Jamaica. Robinson RD, Lindo JF, Neva FA, Gam AA, Vogel P, Terry SI, Cooper ES. J Infect Dis; 1994 Mar; 169(3):692-6. PubMed ID: 8158055 [Abstract] [Full Text] [Related]
10. Is the prevalence of HTLV-1 infection higher in Strongyloides carriers than in non-carriers? Arakaki T, Asato R, Ikeshiro T, Sakiyama K, Iwanaga M. Trop Med Parasitol; 1992 Sep; 43(3):199-200. PubMed ID: 1470843 [Abstract] [Full Text] [Related]
11. Secondary Strongyloides stercoralis prophylaxis in patients with human T-cell lymphotropic virus type 1 infection: report of two cases. Peters L, McCarthy AE, Faught C. Int J Infect Dis; 2009 Nov; 13(6):e501-3. PubMed ID: 19501008 [Abstract] [Full Text] [Related]
13. Seroprevalence of Strongyloides stercoralis infection among HTLV-I infected blood donors in Barcelona, Spain: A cross-sectional study. Salvador F, Sulleiro E, Piron M, Sánchez-Montalvá A, Sauleda S, Molina I. Acta Trop; 2017 Dec; 176():412-414. PubMed ID: 28939495 [Abstract] [Full Text] [Related]
14. Coinfection by Strongyloides stercoralis in blood donors infected with human T-cell leukemia/lymphoma virus type 1 in São Paulo City, Brazil. Chieffi PP, Chiattone CS, Feltrim EN, Alves RC, Paschoalotti MA. Mem Inst Oswaldo Cruz; 2000 Dec; 95(5):711-2. PubMed ID: 10998221 [Abstract] [Full Text] [Related]
15. Severe strongyloidiasis complicated by meningitis and hydrocephalus in an HTLV-1 carrier with increased proviral load. Satoh M, Futami A, Takahira K, Kodaira M, Tanaka T, Kuriki K, Hori E. J Infect Chemother; 2003 Dec; 9(4):355-7. PubMed ID: 14691660 [Abstract] [Full Text] [Related]
16. Strongyloidiasis and infective dermatitis alter human T lymphotropic virus-1 clonality in vivo. Gillet NA, Cook L, Laydon DJ, Hlela C, Verdonck K, Alvarez C, Gotuzzo E, Clark D, Farré L, Bittencourt A, Asquith B, Taylor GP, Bangham CR. PLoS Pathog; 2013 Dec; 9(4):e1003263. PubMed ID: 23592987 [Abstract] [Full Text] [Related]
17. Association between Strongyloides stercoralis infection and biliary tract cancer. Hirata T, Kishimoto K, Kinjo N, Hokama A, Kinjo F, Fujita J. Parasitol Res; 2007 Oct; 101(5):1345-8. PubMed ID: 17611780 [Abstract] [Full Text] [Related]
20. Predictive markers for development of strongyloidiasis in patients infected with both Strongyloides stercoralis and HTLV-1. Satoh M, Kiyuna S, Shiroma Y, Toma H, Kokaze A, Sato Y. Clin Exp Immunol; 2003 Sep; 133(3):391-6. PubMed ID: 12930366 [Abstract] [Full Text] [Related] Page: [Next] [New Search]